PAVmed Analyst Ratings
PAVmed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | Cantor Fitzgerald | $4 → $1.5 | Downgrades | Overweight → Neutral |
| 01/18/2023 | 226.87% | Lake Street | $5 → $1.5 | Maintains | Buy |
| 08/17/2022 | 989.56% | Lake Street | $7 → $5 | Maintains | Buy |
| 03/30/2021 | 1643.3% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 989.56% | Ascendiant Capital | → $5 | Initiates Coverage On | → Buy |
| 10/13/2020 | 989.56% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 06/28/2018 | 989.56% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | 康託·菲茨傑拉德 | $4→$1.5 | 評級下調 | 超重→中性 |
| 01/18/2023 | 226.87% | 萊克街 | $5→$1.5 | 維護 | 買 |
| 2022/08/17 | 989.56% | 萊克街 | $7→$5 | 維護 | 買 |
| 03/30/2021 | 1643.3% | 康託·菲茨傑拉德 | →$8 | 開始承保 | →超重 |
| 11/05/2020 | 989.56% | 《上升之都》 | →$5 | 開始承保 | →購買 |
| 10/13/2020 | 989.56% | 萊克街 | →$5 | 開始承保 | →購買 |
| 2018/06/28 | 989.56% | Maxim集團 | →$5 | 開始承保 | →購買 |
What is the target price for PAVmed (PAVM)?
PAVmed(PAVM)的目標價是多少？
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Cantor Fitzgerald on January 20, 2023. The analyst firm set a price target for $1.50 expecting PAVM to rise to within 12 months (a possible 226.87% upside). 3 analyst firms have reported ratings in the last year.
康託·菲茨傑拉德於2023年1月20日報道了PAVmed(納斯達克代碼：PAVM)的最新目標價。這家分析公司將目標價定為1.5美元，預計pvm將在12個月內升至(可能上漲226.87%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for PAVmed (PAVM)?
PAVmed(PAVM)的最新分析師評級是多少？
The latest analyst rating for PAVmed (NASDAQ: PAVM) was provided by Cantor Fitzgerald, and PAVmed downgraded their neutral rating.
納斯達克(Sequoia Capital：PAVM)的最新分析師評級由康託·菲茨傑拉德提供，PAVmed下調了其中性評級。
When is the next analyst rating going to be posted or updated for PAVmed (PAVM)?
PAVmed(PAVM)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on January 20, 2023 so you should expect the next rating to be made available sometime around January 20, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與PAVmed的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。PAVmed的上一次評級是在2023年1月20日提交的，所以你應該預計下一次評級將在2024年1月20日左右的某個時候公佈。
Is the Analyst Rating PAVmed (PAVM) correct?
分析師評級PAVmed(PAVM)正確嗎？
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a downgraded with a price target of $4.00 to $1.50. The current price PAVmed (PAVM) is trading at is $0.46, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的PAVmed(PAVM)評級被下調，目標價為4.00美元至1.50美元。目前PAVmed(PAVM)的交易價格為0.46美元，超出了分析師的預測區間。